Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10

AM Tager, RL Kradin, P LaCamera… - American journal of …, 2004 - atsjournals.org
Pulmonary fibrosis is an enigmatic and devastating disease with few treatment options, now
thought to result from abnormal wound healing in the lung in response to injury. We have …

[引用][C] Inhibition of Pulmonary Fibrosis by the Chemokine IP-10/CXCL10

AM Tager, RL Kradin, P LaCamera… - American Journal of …, 2004 - cir.nii.ac.jp
Inhibition of Pulmonary Fibrosis by the Chemokine IP-10/CXCL10 | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10

AM Tager, RL Kradin, P LaCamera… - … of respiratory cell …, 2004 - pubmed.ncbi.nlm.nih.gov
Pulmonary fibrosis is an enigmatic and devastating disease with few treatment options, now
thought to result from abnormal wound healing in the lung in response to injury. We have …

Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.

AM Tager, RL Kradin, P LaCamera… - American Journal of …, 2004 - europepmc.org
Pulmonary fibrosis is an enigmatic and devastating disease with few treatment options, now
thought to result from abnormal wound healing in the lung in response to injury. We have …

Inhibition of Pulmonary Fibrosis by the Chemokine IP-10/CXCL10

AM Tager, RL Kradin, P LaCamera… - American Journal of …, 2004 - search.proquest.com
Pulmonary fibrosis is an enigmatic and devastating disease with few treatment options, now
thought to result from abnormal wound healing in the lung in response to injury. We have …

[引用][C] Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10

AM TAGER, RL KRADIN… - … of respiratory cell …, 2004 - American Thoracic Society